Press & events

What's happening?

Stay updated on our latest news and events.

Displaying 21 - 30 of 406

Press

Invitation to the presentation of Recipharm’s interim report for the third quarter 2020

2020.11.02 Read more

Press

Recipharm’s proprietary molecule Erdosteine has been positively tested as part of COVID-19 treatment

2020.10.14 Read more

Press

Recipharm invests EUR 2.6 million in Kaysersberg facility

2020.10.13 Read more

Press

Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR[®]-COV19 (ARCT-021) vaccine candidate

2020.10.06 Read more

Press

BIAL and Recipharm expand long-term supply agreement for opicapone API

2020.10.01 Read more

Press

Recipharm divests Portuguese distribution business and ophthalmology company for approximately EUR 31 million

2020.09.30 Read more

Press

Sobrera Pharma and Recipharm in collaboration to advance a new treatment for patients with Alcohol Use Disorder

2020.09.24 Read more

Press

Change in the total number of shares and votes in Recipharm AB (publ)

2020.07.31 Read more

Press

Recipharm AB publishes its interim report for the second quarter 2020

2020.07.27 Read more

Press

Invitation to the presentation of Recipharm’s interim report for the second quarter 2020

2020.07.22 Read more